Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Gialafos, A. Rapti, V. Kouranos, E. Manali, T. Papaioannou, E. Kosmas, A. Kalianos, C. Kostopoulos, E. Stampoulis, S. Papiris, N. Koulouris, A. Wells (Athens, Greece; London, United Kingdom). BNP can be an all-cause mortality predictor in sarcoidosis. Eur Respir J 2013; 42: Suppl. 57, 3783

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Radiologic pattern as a survival predictor in the rheumatoid artritis intersticial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Chronic obstructive pulmonary disease as a predictor of lung cancer mortality Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Recurrence predictive factors of cryptogenic organizing pneumonia Source: International Congress 2015 – Connective tissue disorders Year: 2015 Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Determinants and assessment of excess cardiovascular risk in bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Prevalence of smoking among Polish sarcoid patients Source: International Congress 2016 – Sarcoidosis Year: 2016 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Smoking and interstitial lung diseases Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Cardiac symptoms are a survival predictor in sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Predicting progression of RA-ILD using anti-CCP Source: International Congress 2015 – Connective tissue disorders Year: 2015